Biotech interview prep when AI ranks discovery hits

Check controls, count independent repeats and explain what would change your research plan.

Try a biotech interview

What companies say they’re looking for

03 Compare within batches

“However, fluctuating instrument readouts, known as batch effects, can obscure biological patterns.” (opens the source)

Martin Wasser and coauthors, Cytometry study authors · Singapore · Cytometry Part A, May 18, 2026

The Singapore study describes how instrument variation can obscure biological patterns. Check whether a pooled comparison holds within each batch.

05 Decide what can advance

“The advancement of the first unexplored neuroscience target from our collaboration with Genentech into an early discovery program is an important milestone” (opens the source)

Najat Khan, Chief Executive Officer, Recursion · Recursion, Aug 5, 2026

Khan describes one target advancing into joint early discovery. Use the criteria in the fictional case to decide which hit has independent confirmation.

Sources

  1. Julio Saez-Rodriguez, Head of Research, EMBL-EBI · United Kingdom, at the time. EMBL-EBI, “Benchmarking: the foundation of reliable AI in biomedicine”, Sep 17, 2026. Open the source. Checked against the published text.
  2. Cyprotex, Associate Scientist posting · Alderley Park, England, at the time. Evotec Careers, “Associate Scientist”, Nov 10, 2026. Open the source. Checked against the published text.
  3. Martin Wasser and coauthors, Cytometry study authors · Singapore, at the time. Cytometry Part A, “Dissecting the Influence of Batch Effects on Immunomics Pattern Discovery in High-Dimensional Mass Cytometry”, May 18, 2026. Open the source. Checked against the published text.
  4. P. S. Reynolds, University of Florida · article author, at the time. eNeuro, “Experimental Designs for Preclinical Neuroscience Experiments: Part I—Design Basics”, Feb 25, 2026. Open the source. Checked against the published text.
  5. Najat Khan, Chief Executive Officer, Recursion, at the time. Recursion, “Unlocking the First Neuroscience Target for the Recursion and Genentech Collaboration”, Aug 5, 2026. Open the source. Checked against the published text.

Last reviewed Nov 11, 2026